Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-23-000269
Filing Date
2023-02-17
Accepted
2023-02-17 17:04:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 atyrpharma.htm SC 13G/A 57912
  Complete submission text file 0000935836-23-000269.txt   59425
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Subject) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88839 | Film No.: 23643726
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 919 NW BOND STREET SUITE 204 BEND OR 97703
Business Address 919 NW BOND STREET SUITE 204 BEND OR 97703 541-647-5673
Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

EIN.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A